Psychosocial Screening in Sickle Cell Disease: Validation of the Psychosocial Assessment Tool.

Journal of Pediatric Psychology
Steven K ReaderAnne E Kazak

Abstract

Families of youth with Sickle Cell Disease (SCD) can face psychosocial adversity including emotional distress, functional impairments, and sociodemographic risk factors. Systematic screening of psychosocial risk can identify families who may benefit from further assessment and evidence-based care. The Psychosocial Assessment Tool (PAT) is a brief caregiver-report screener based on the tri-level Pediatric Psychosocial Preventative Health Model (PPPHM). Findings are presented from the baseline assessment of a longitudinal study validating a Sickle Cell version of the PAT 2.0. Primary caregivers of 136 youth with SCD receiving care through a multidisciplinary SCD clinic in a children's hospital completed the PAT and validation measures. A subset of 25 caregivers completed the PAT a second time within 3-5 weeks. Internal consistency for the total score was strong (α = .87), and for the subscales was moderate to strong (α  =  .74-.94), with the exception of the Family Structure (α  =  .38), Caregiver Beliefs (α  =  .48), and Stress Reactions (α  =  .56) subscales. Test-retest reliability was also strong (r = .86, p < .001). Moderate to strong correlations with all except two criteria measures provided validation for the total and su...Continue Reading

References

Nov 24, 1998·European Child & Adolescent Psychiatry·R GoodmanV Bailey
May 4, 2005·Behaviour Research and Therapy·Ariel J Lang, Murray B Stein
Jun 15, 2005·British Journal of Haematology·Kofi A Anie
Nov 7, 2007·Journal of Pediatric Hematology/oncology·Lamia P BarakatCarlton Dampier
Jun 3, 2009·Journal of Pediatric Psychology·Grayson N Holmbeck, Katie A Devine
Jul 1, 2003·Journal of the National Comprehensive Cancer Network : JNCCN·UNKNOWN National Comprehensive Cancer Network
Apr 2, 2010·American Journal of Preventive Medicine·Sheree L BouletRichard S Olney
Nov 23, 2010·Journal of Pediatric Psychology·Martin Pinquart, Yuhui Shen
Dec 9, 2010·Pediatrics·Jay G BerryJudith S Palfrey
Feb 12, 2011·Current Psychiatry Reports·Tami D BentonKim Smith-Whitley
Apr 24, 2012·Pediatric Blood & Cancer·Julie A Panepinto, Melanie Bonner
Apr 25, 2012·Maternal and Child Health Journal·Ashley Busacker, Laurin Kasehagen
Oct 2, 2012·Pediatric Blood & Cancer·Stephen C Nelson, Heather W Hackman
Nov 16, 2012·Pediatric Blood & Cancer·Matthew P MyrvikJulie A Panepinto
Jun 28, 2013·Cardiology in the Young·Simone J HearpsVicki A Anderson
Aug 24, 2013·Journal of Pediatric Gastroenterology and Nutrition·Ahna L H PaiKevin A Hommel
Dec 12, 2013·Journal of Pediatric Hematology/oncology·Aimee K HildenbrandMeghan L Marsac
Apr 10, 2018·The Journal of Pediatrics·Thao-Ly T PhanAnne E Kazak
Aug 16, 2019·Journal of Clinical Psychology in Medical Settings·Steven K ReaderAnne E Kazak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.